FDA Approved: RENFLEXIS — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for Renflexis (infliximab) submitted by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Crohn Disease
• Juvenile Idiopathic Arthritis
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• RENFLEXIS (Infliximab)

Snippet

SUPPL AP for RENFLEXIS (INFLIXIMAB)